Cancer Risks, Screening and Prevention for People with ATM, CHEK2, PALB2 and Other Genes
September 29, 2021
Learn about the cancer risks associated with an inherited mutation in ATM, CHEK2, PALB2 and other genes and the risk-management options for people with an inherited mutation in one of these genes. This session is presented by Allison Kurian, MD (Stanford University School of Medicine).
People who have been diagnosed with an ATM, BRIP1, CHEK2, PALB2, PTEN, RAD51C, RAD51D or another mutation, their relatives and caregivers, and people with a personal or family history of cancer who are interested in learning more about genetic testing for inherited cancer risk.